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In this issue, Vandeputte et al. present a unique study exploring the effects of 
chicory-derived inulin on the human gut microbiota by combining Next Generation 
Sequencing and fecal metabolomics to gain new insights into the mechanisms of 
action underlying inulin health promoting effects.[1] The study supports that inulin 
prebiotics stimulate growth of bifidobacteria while simultaneously driving a number 
of other modulations of the gut microbial ecosystem that may be associated with 
health-promoting effects. 
 
Consumption of inulin-type fructans (ITFs) has been associated with a number of 
health benefits, including normalisation of gastrointestinal function, regulation of 
body weight gain and energy metabolism. [2] Some of the suggested mechanisms of 
action include regulation of the immune system, modulation of gastrointestinal 
peptides, production of SCFAs and modulation of triglyceride metabolism. [2-4] 
Down in the intestine, ITFs have long been known for their prebiotic activity targeted 
towards the enhancement of the genus bifidobacteria.[5] The later is a well-known 
inhabitant of the human gut and one of the first micro-organism to colonize the 
infant’s intestine at birth. Bifidobacteria are believed to promote health by 
producing some antimicrobial substances protecting the host from opportunistic 
pathogens, in addition to large amounts of lactic acid, which contribute to maintain a 
low pH in the colon thereby limiting pathogen growth. Yet, inulin prebiotic effects on 
human’s gut microbial ecology have so far mostly been assessed using culture-based 
methods or targeted quantitative PCR (Polymerase Chain Reaction) and FISH 
(Fluorescent In Situ Hybridization), which limited our ability to assess the full extent 
of their impact on the gut microbial community. In this issue, Vandeputte et al. filled 
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this caveat by applying for the first time a Next Generation Sequencing technology to 
capture the untargeted impact of inulin prebiotic consumption on the human gut 
microbiota.[1] 
 
In this double blind, randomized, placebo-controlled, cross-over diet intervention 
study, 44 healthy volunteers with constipation consumed either a chicory-derived 
inulin mix or maltodextrin for 4 weeks on a daily basis. The full details of the original 
experimental design and results on gastrointestinal parameters were published 
previously,[6] and indicated that inulin intake significantly improved stool frequency. 
The present study reports the results of the gut microbiota phylogenetic analysis 
complemented by some fecal metabolomics data. Focusing on the V4 hypervariable 
region of the 16S rDNA, the authors first demonstrated that inulin intake shifted the 
gut microbial composition towards a significant increase of Bifidobacterium and 
Anaerostipes spp. concomitant with a reduction in Bilophila population. Although an 
increase in bifidobacteria has been consistently observed in association with ITFs 
consumption, this is the second report of an increase in Anaerostipes spp. in 
humans.[3] Indeed, Dewulf et al. reported a number of inulin-induced microbial 
modulations in obese women, including an increase in Anaerostipes caccae, 
Lactobacillus gasseri and Faecalibacterium prausnitzii populations.[3] These are 
important findings because some Anaerostipes species and Faecalibacterium 
prausnitzii have been reported to be butyrate producers and therefore of potential 
health benefit for the host. [7,8] 
A reduction in Bilophila population is also an interesting outcome because these 
bacteria of the Desulfivibrionacaeae family are sulfite reducing organisms known to 
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produce hydrogen sulphide (H2S) toxic for the host.[9] In addition, the change in 
Bilophila population was significantly correlated with discomfort; the bigger its 
reduction, the lower discomfort score was reported. This indicates that some of the 
potentially beneficial effects of ITFs may be mediated by the selective reduction of 
Bilophila spp. in the gut microbial community. Interestingly, a similar decrease in 
Bilophila spp. following inulin intake had been reported in rodents using a similar 
deep sequencing approach, where it was also associated with improved gut barrier 
function.[10] Previous studies in human volunteers have reported various inulin- and 
FOS-triggered modulations of gut bacterial groups independent of bifidobacteria 
(reviewed by Gibson et al.[11]), of which a decrease in enterobacteria populations 
that also contain a number of opportunistic pathogens.[11] Altogether, this suggests 
that inulin may provide health benefits by promoting a colonic environment 
unfavourable for some pathogens. 
 
In this context, it is pertinent to get an insight into the modulations of the gut 
luminal environment, which may be modified as a result of an alteration of gut 
microbial metabolic activity. The authors therefore investigated the fecal 
metabolome following inulin intake by GC-MS (Gas Chromatography coupled with 
Mass Spectrometry). Unlike other studies that captured an increase in short chain 
fatty acids following inulin intake, no effects on known metabolic products of 
bifidobacteria were reported here. Nevertheless, the particular GC-MS protocol used 
for the metabolomics analysis in this study did not allow detection of a number of 
major bacterial metabolites, such as lactic acid. This constitutes the main limitation 
of the study and hence it precludes any conclusion about the influence of the 
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prebiotic treatment over gut bacterial metabolism. This is regrettable since a proper 
evaluation of functional modulations of active ingredients designed to target the gut 
microbial ecosystem is necessary to assess their potential as a modulator of 
microbiota function. Indeed, although it is possible to infer the metabolic potential 
of a microbial ecosystem based on its metagenome, only a direct measurement of 
the metabolites released by the microbial population can accurately reflect the 
metabolic adjustments of the micro-organisms to a diet challenge. Such information 
is useful to control for inter-individual variability to diet interventions, as we must be 
able to measure an individual’s response to functional foods to ultimately determine 
the individual health benefit. Exploring metabolic variations in a wider range of 
biological compartments, such as urine where many microbial co-metabolites 
accumulate, would also be helpful to depict a more accurate picture of the host-
microbiota metabolic response to a prebiotic intervention. 
 
So is inulin prebiotic all about bifidobacteria? On one hand, this study confirms that 
the invariable bacterial response to inulin challenge remains an increase in 
bifidobacteria populations, which has been consistently reported over the last 20 
years. On the other hand, it suggests that these effects are accompanied by other 
ecological changes that should not be disregarded for their health-promoting 
consequences, which argues in favour of a broader definition of prebiotics as 
previously suggested.[12] It is likely that the reason why we have not been able to 
consistently report such alterations is due to the fact that this aspect of the microbial 
response to inulin is more prone to inter-individual variations and could not be 
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captured using targeted microbiological methods. Yet, it appears that these 
idiosyncratic bacterial community shifts deserve serious consideration. 
 
In conclusion, the work of Vandeputte et al.[1] brings us one step closer to designing 
personalised diets based on an individual predictable response to prebiotics. Future 
studies will largely benefit from using a similar holistic approach based on a 
comprehensive assessment of an individual’s metabolism combining multiple ‘omics’ 
technologies that provide insights into an individual’s genome, microbiome and 
metabolome. 
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